IMGT

公司沿革

  • 2023

    • 12

      Designated as an excellent corporate research institute

    • 11

      IMD20 Medical Device clinical trial approval

    • 09

      Signed MOU with Samsung Medison

    • 08

      IMP101 Medical Device clinical trial approval

    • 08

      Signed MOU with Viol

    • 08

      IMP301 Approval of Clinical Trials for Pharmaceutical Product
      (Investigational New Drug ; IND)

    • 07

      Selected for the Industrial Technology innovation Project-materials,
      components, and Technology development-($17 Million)

    • 07

      Listed on the KONEX market

  • 2022

    • 10

      Received the 7th LeeMinHwa’s Medical Entrepreneurship Award (CEO, Hakjoing Lee)

    • 08

      IMD10 Medical Device clinical trial approval

    • 07

      ISO:9001 approval

    • 06

      Signed MOU with Bundang Convergence Technology Education Center
      (Korea Polytechnics)

    • 03

      MAINBiz approval

    • 02

      Selected for Scale-up TIPS Project

  • 2021

    • 12

      Series C Funding

    • 12

      Signed MOU with HysensBio

    • 09

      Signed MOU with ToolGen

    • 06

      Participation and Sponsorship at International Symposium for Therapeutic Ultrasound (ISTU 2021)

    • 04

      Medical device GMP approval review

    • 04

      Selected for medical device suitability support project

    • 02

      Selected IPO underwriter (DB Financial Investment)

  • 2020

    • 12

      Signed MOU with Dongkook Life Science

    • 11

      Series B-2(Bridge) Funding

    • 08

      Selected for the full cycle governmental project ($ 5 million)

    • 06

      Signed MOU with Huons

    • 05

      Selected for recruitment support project for young researchers

  • 2019

    • 10

      Contract out ultrasound device design to Cheongju University

    • 09

      Participation and Sponsorship at Korean Society for Therapeutic Ultrasound (KSTU 2019)

    • 05

      Office relocation and expansion

    • 04

      Appointed CTO

    • 02

      Appointed CFO

  • 2018

    • 12

      Series B Funding

    • 09

      Selected for high-tech medical technology development project by the Ministry of Health and Welfare, 4th year agreement

  • 2017

    • 11

      Selected for high-tech medical technology development project by the Ministry of Health and Welfare, 3rd year agreement

    • 10

      Selected for Gyeonggi Province technology development project

    • 09

      Selected for TIPS Program’s Global Advancement Support by Small and Medium Business Administration(SMBA)

    • 05

      Selected for R&D planning support project by SMBA

  • 2016

    • 12

      Series A Funding

    • 11

      Selected for high-tech medical technology development project by the Ministry of Health and Welfare, 2nd year agreement

    • 10

      Established Company’s R&D center

    • 05

      Selected as a planning task force for the Medi-Bio Cluster by Seongnam District’s Industry Promotion Agency

  • 2015

    • 11

      Selected for high-tech medical technology development project by the Ministry of Health and Welfare, 1st year agreement

    • 10

      Selected for TIPS project by Small and Medium Business Administration

  • 2010

    • 10

      Registered as a Venture Company by the Korean Government

    • 04

      Established IMGT

이용약관

닫기

개인정보처리방침

닫기

이메일무단수집거부

닫기

SITE MAP

IMGT
技术平台
新闻中心
加入我们
닫기